Science Explorer Interactive view Map
Company · South San Francisco · United States

Sutro Biopharma (United States)

sutrobio.comROR OpenAlex
Research works
67
▲ 46% vs 2013–17
Citations
1.8k
27.0 per fractional work
Top-10% rate
22.1%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: Sutro Biopharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.32× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 6.43× its world share, 2 worksImmunology and Micro…Neuroscience: 3.13× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.03× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.16× its world share, 0 worksChemistryComputer Science: 0.33× its world share, 1 worksComputer ScienceEngineering: 0.39× its world share, 1 worksEngineeringEnvironmental Science: 0.15× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.42× its world share, 0 worksMaterials ScienceMedicine: 2.98× its world share, 13 worksMedicineVeterinary: 3.64× its world share, 0 worksVeterinaryEconomics, Econometrics and Finance: 0.11× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.4×. Every wedge is a field page.

Who are the top researchers at Sutro Biopharma (United States)?

Ranked on the composite score, Gang Yin and Trevor J. Hallam lead among researchers whose main affiliation is Sutro Biopharma (United States).

  1. 1 Gang Yin United States · #732,069 worldwide 61 citations · 15 works
  2. 2 Trevor J. Hallam United States · #1,017,613 worldwide 77 citations · 21 works
All ranked researchers at Sutro Biopharma (United States)

Which keywords describe research at Sutro Biopharma (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors, Immunotherapy, Tumor Regression, Cancer Immunotherapy and Lymphoma.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Monoclonal Antibodies4▲ 185×2 topics
  2. Therapeutic Antibodies4▲ 238×2 topics
  3. Antibody Engineering3▲ 273×1 topic
  4. Fc Receptors3▲ 273×1 topic
  5. Cancer Immunotherapy3▲ 76×2 topics
  6. Immunotherapy3▲ 17×3 topics
  7. Tumor Regression3▲ 107×2 topics
  8. Lymphoma3▲ 70×3 topics
  9. CAR T Cells2▲ 128×1 topic
  10. Chimeric Antigen Receptor2▲ 128×1 topic
  11. Leukemia2▲ 112×2 topics
  12. Chemotherapy2▲ 12×3 topics
  13. Tumor Microenvironment2▲ 17×3 topics
  14. Monoclonal Antibody2▲ 143×2 topics
  15. PET Imaging2▲ 42×3 topics
  16. Targeted Therapy1▲ 27×3 topics
  17. Breast Cancer1▲ 25×1 topic
  18. Clinical Trials1▲ 8.2×2 topics
  19. HER21▲ 203×1 topic
  20. BET Bromodomains1▲ 163×1 topic
  21. PROTACs1▲ 163×1 topic
  22. Transcriptional Regulation1▲ 30×2 topics
  23. Atomic Layer Deposition1▲ 62×1 topic
  24. Calcium Signaling1▲ 61×1 topic
  25. High-k Dielectrics1▲ 62×1 topic
  26. Ion Channels1▲ 40×1 topic

Which research topics does Sutro Biopharma (United States) publish most on?

By volume in 2022–2025: Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, HER2/EGFR in Cancer Research and Protein Degradation and Inhibitors.

Monoclonal and Polyclona…3Monoclonal and Polyclonal Antibodies Research: 3 fractional worksCAR-T cell therapy research: 2 fractional worksHER2/EGFR in Cancer Research: 1 fractional worksProtein Degradation and Inhibitors: 1 fractional worksIon Channels and Receptors: 1 fractional worksSemiconductor materials …1Semiconductor materials and devices: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksPeptidase Inhibition and Analysis: 1 fractional worksComputational Drug Discovery Methods: 1 fractional works
Radiology, Nuclear Medicine and ImagingOncologyMolecular BiologySensory Systems3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 3 works
  2. 2 CAR-T cell therapy research Oncology 2 works
  3. 3 HER2/EGFR in Cancer Research Oncology 1 works
  4. 4 Protein Degradation and Inhibitors Molecular Biology 1 works
  5. 5 Ion Channels and Receptors Sensory Systems 1 works
  6. 6 Semiconductor materials and devices Electrical and Electronic Engineering 1 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  8. 8 Cancer Immunotherapy and Biomarkers Oncology 1 works
  9. 9 Peptidase Inhibition and Analysis Oncology 1 works
  10. 10 Computational Drug Discovery Methods Computational Theory and Mathematics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.0%not open61.0%

World: 28% of research is openly available.

with international co-authors9.9%domestic only90.1%

World: 19% is written across borders.

How has Sutro Biopharma (United States)'s research output changed?

Output in 2018–2022 was 46% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.